ImmunoGen
FDA Approves Elahere to Treat Platinum-Resistant Ovarian Cancer
Mirvetuximab soravtansine-gynx was approved to treat adults with folate receptor alpha-positive, platinum-resistant ...
NOVEMBER 21, 2022

Load more